Quo-Lab meets strict international quality targets – confirming it fit for purpose for diabetes testing The study aimed to evaluate the four POC HbA1c instruments according to Clinical and Laboratory ...

EKF Diagnostics has announced that its Quo-Lab HbA1c point-of-care analyzer has successfully achieved International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) certification. The ...

EKF Diagnostics, the global in vitro diagnostics company, has announced the successful evaluation of its Quo-Lab® point-of-care HbA1c analyzer by the European Reference Laboratory for Glycohemoglobin.

Swansea University, College of Medicine, presents scientific poster at IDF 2013 Glycated hemoglobin (HbA1c) is widely used as a means of monitoring diabetes control and has recently been recommended ...

EKF Diagnostics Holdings plc (AIM: EKF), the AIM quoted point-of-care business, announces that it has signed a three-year distribution agreement with Tosoh Europe N.V., part of Tosoh Corporation, the ...

EKF Diagnostics Holdings plc (AIM: EKF), the AIM quoted point-of-care business, announces that it has signed a three-year distribution agreement with Tosoh Europe N.V., part of Tosoh Corporation, the ...

Dublin, Oct. 08, 2025 (GLOBE NEWSWIRE) -- The "HbA1c Analyzers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product ...